Minimally invasive endocrine procedures

🔬 Keyhole Endocrine Intro

• Principle: Accessing endocrine glands (thyroid, parathyroid, adrenal) via small, remote incisions, avoiding large neck or abdominal wounds.
• Core Advantages: ↓ post-op pain, ↓ blood loss, shorter hospital stay, and superior cosmesis compared to traditional open surgery.
• Common Procedures:
  • Minimally Invasive Parathyroidectomy (MIP)
  • Endoscopic Thyroidectomy (transoral, axillary approaches)
  • Laparoscopic/Robotic Adrenalectomy
• Tools: Endoscopes, specialized long instruments, and robotic platforms (e.g., da Vinci).

⭐ Precise preoperative localization (e.g., Sestamibi scan, 4D-CT, ultrasound) is paramount for the success of minimally invasive approaches, especially for parathyroid adenomas.

🔪 Management - Thyroid's Tiny Tuck

• Minimally Invasive Thyroidectomy (MIT): Techniques using small or hidden incisions for improved cosmesis and potentially faster recovery compared to conventional open surgery.

• Key Selection Criteria:

  • Benign nodules or low-risk differentiated thyroid cancer
  • Maximum nodule diameter < 3-4 cm
  • Thyroid lobe volume < 30-40 mL
  • No prior neck surgery or radiation
  • No extrathyroidal extension or lymph node metastases

• Common Approaches:

  • MIVAT: Minimally invasive video-assisted; small central neck incision.
  • TOETVA: Transoral endoscopic; no visible neck scar.
  • Transaxillary: Through an armpit incision.

⭐ TOETVA (Transoral Endoscopic Thyroidectomy Vestibular Approach) is a truly "scarless" neck surgery, accessing the thyroid via incisions inside the lower lip.

🎯 Management - Parathyroid Pinpointing

Preoperative localization is key for minimally invasive parathyroidectomy (MIP), targeting a single adenoma (~85% of cases).

• Primary Localization Studies:

  • Neck Ultrasound (US): High sensitivity for cervical glands; operator-dependent.
  • Sestamibi Scan (⁹⁹ᵐTc): Functional scan; detects hyperfunctioning tissue, including ectopic glands. Often fused with SPECT/CT.

• Localization Algorithm:

⭐ Intraoperative PTH (ioPTH) Monitoring: Confirms successful resection. A >50% drop from baseline 10 minutes post-excision indicates cure (Miami criterion).

🥷 Adrenal's Stealth Removal

• Laparoscopic Adrenalectomy (LA): Gold standard for most benign, functioning adrenal tumors (Conn's, Cushing's) and pheochromocytomas, typically < 6-8 cm.
• Approaches:
  • Transperitoneal (TLA): Standard anterior approach; excellent visualization.
  • Posterior Retroperitoneoscopic (PRA): Direct posterior access. 💡 Advantageous for bilateral tumors, morbid obesity, and patients with prior extensive abdominal surgery.

⭐ Pheochromocytoma Prep: Crucial pre-op alpha-blockade (e.g., phenoxybenzamine) followed by beta-blockade is mandatory to prevent intraoperative catecholamine surge and hypertensive crisis.

⚠️ Complications - Tiny Access Troubles

• Gas-Related (CO₂ Insufflation):
  • Subcutaneous emphysema: Common, benign crepitus.
  • Hypercarbia/Acidosis: Monitor end-tidal CO₂.
  • Gas embolism: Rare but lethal. Sudden ↓ETCO₂, hypotension.
• Procedure-Specific Nerve Injury:
  • Thyroid/Parathyroid: RLN (hoarseness), SLN (voice pitch change).
• Other:
  • Port-site issues (hernia, bleeding), visceral/vascular injury (adrenalectomy).

⭐ A sudden, sharp drop in end-tidal CO₂ (ETCO₂) during insufflation is a classic sign of a CO₂ gas embolism.

⚡ Biggest Takeaways

• Minimally Invasive Parathyroidectomy (MIP) is standard for localized adenomas; success is confirmed by a >50% drop in intraoperative PTH.
• Laparoscopic adrenalectomy is the gold standard for most benign tumors (pheo, Conn's); avoid for large (>6 cm) or suspected adrenocortical carcinomas.
• Minimally Invasive Thyroidectomy is for small (<3-4 cm), low-risk nodules; recurrent laryngeal nerve injury risk is similar to open surgery.
• Preoperative localization (sestamibi, US, CT) is critical for patient selection.